Clinical and microbiological characterization of Staphylococcus lugdunensis isolates obtained from clinical specimens in a hospital in China

Table 3 Results of drug susceptibility test assayed by the Kirby-Bauer and E-Test and β-lactamase assay

ID	SA¹	CFZ¹	E¹	FOS¹	FOX¹	GM¹	DA¹	LVX¹	LZD¹	P¹	RA¹	CXM¹	SXT¹	VA²	β-lactamase
1	27	34	6(R)^*	30	30	26	18(R)^*	29	34	15(R)^*	32	34	28	1.2	+
2	28	34	6(R)^*	30	30	28	6(R) ^*	26	32	14(R)^*	34	32	26	1.0	+
4	40	44	36	46	28	30	36	28	36	40	40	40	32	1.5	-
6	20	38	6(R)^*	26	35	26	6(R) ^*	29	34	9(R) ^*	38	40	26	1.0	+
8	21	24	32	26	18(R)^*	27	34	26	34	14(R)^*	40	23	32	0.8	+

¹Inhibition zone (mm); ²Minimum inhibition concentration (MIC) (μg/ml); *Drug resistant (R).
ID identification directory, SA ampicillin/sulbactam, CFZ cefazolin, ERM erythromycin, FOS fosfomycin, FOX: cefoxitin, GM gentamicin, DA clindamycin, LVX levofloxacin, LZD linezolid, P penicillin, RA rifampicin, CXM cefuroxime, SXT trimethoprim + sulfamethoxazole, VA vancomycin).

ISSN: 1471-2180